COVID-19 Lockdown in Patients with Chronic Diseases: A Cross-Sectional Study

Mathieu Boulin, Amélie Cransac-Miet, Marc Maynadié, Fabienne Volot, Catherine Creuzot-Garcher, Jean-Christophe Eicher, Frédéric Chagué, Eléa Ksiazek, Guillaume Beltramo, Philippe Bonniaud, Thibault Moreau, Bernard Bonnotte, Edith Sales-Wuillemin, Agnès Soudry-Faure, Marianne Zeller and Yves Cottin
Additional contact information
Mathieu Boulin: Pharmacy Department, Dijon Bourgogne University Hospital, EPICAD LNC UMR 1231, 21000 Dijon, France
Amélie Cransac-Miet: Pharmacy Department, Dijon Bourgogne University Hospital, EPICAD LNC UMR 1231, 21000 Dijon, France
Marc Maynadié: Biological Haematology Department, Dijon Bourgogne University Hospital, Haematological Malignancies Registry, LNC UMR 1231, 21000 Dijon, France
Fabienne Volot: Haemophilia Comprehensive Care Centre, Dijon Bourgogne University Hospital, 21000 Dijon, France
Catherine Creuzot-Garcher: Eye and Nutrition Research Group, Ophthalmology Department, Dijon Bourgogne University Hospital, UMR1324, INRAE, 6265 CNRS, 21000 Dijon, France
Jean-Christophe Eicher: Cardiology Department, Dijon Bourgogne University Hospital, 21000 Dijon, France
Frédéric Chagué: Cardiology Department, Dijon Bourgogne University Hospital, 21000 Dijon, France
Eléa Ksiazek: Department of Clinical Research and Innovation (DRCI), Clinical Research Unit-Methodological Support Network (USMR), Dijon Bourgogne University Hospital, 21000 Dijon, France
Guillaume Beltramo: Reference Constitutive Center for Rare Pulmonary Diseases, Pulmonary Medicine and Intensive Care Unit Department, Dijon Bourgogne University Hospital, LNC UMR 1231, 21000 Dijon, France
Philippe Bonniaud: Reference Constitutive Center for Rare Pulmonary Diseases, Pulmonary Medicine and Intensive Care Unit Department, Dijon Bourgogne University Hospital, LNC UMR 1231, 21000 Dijon, France
Thibault Moreau: Neurology Department, Dijon Bourgogne University Hospital, Bio-PeroxyIL, EA 7270, 21000 Dijon, France
Bernard Bonnotte: Department of Internal Medicine and Clinical Immunology, Dijon Bourgogne University Hospital, INSERM U1098, 21000 Dijon, France
Edith Sales-Wuillemin: Psy-DREPI (Psychologie: Dynamiques Relationnelles et Processus Pdentitaires), University of Bourgogne Franche-Comté, EA 7458, 21000 Dijon, France
Agnès Soudry-Faure: Department of Clinical Research and Innovation (DRCI), Clinical Research Unit-Methodological Support Network (USMR), Dijon Bourgogne University Hospital, 21000 Dijon, France
Marianne Zeller: Cardiology Department, Dijon Bourgogne University Hospital, PEC2, EA 7460, 21000 Dijon, France
Yves Cottin: Cardiology Department, Dijon Bourgogne University Hospital, PEC2, EA 7460, 21000 Dijon, France

IJERPH, 2022, vol. 19, issue 7, 1-12

Abstract: Background: We aimed to investigate the impact of the first COVID-19 lockdown on medication adherence, physician access, lifestyle behaviours, and mental health in patients with chronic conditions. Methods: A cross-sectional phone survey was conducted in 1274 housebound adults recruited from 8 regional chronic disease cohorts (CLEO CD study: NCT04390126). Results: Medication adherence was 97%; 305 (41%) patients declared that at least one scheduled visit with a physician was missed during the first lockdown. The main changes in lifestyle behaviours were deterioration in sleep time (duration and/or quality; 71%), increase in screen time (46%), and decrease in physical activity (46%). Nineteen percent experienced psychological distress (Kessler-6 score ≥ 5). An urban living place (OR, 1.76 vs. rural; 95% CI, 1.32–2.33; p = 10 −4 ), worse self-reported mental health (OR, 1.62 vs. about the same or better; 95% CI, 1.17–2.25; p = 0.003), and a K6 score ≥ 5 (OR, 1.52 vs. <5; 95% CI, 1.05–2.21; p = 0.03) were independent factors associated with at least one unhealthy behaviour. Conclusions: Encouraging results were observed in terms of medication adherence. Caution is needed in chronic disease patients living in urban places as well as those presenting psychological distress and worse self-reported mental health to reduce unhealthy behaviours.

Keywords: COVID-19; lockdown; chronic diseases; medication adherence; physician access; lifestyle behaviours; mental health; unhealthy behaviours (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/7/3957/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/7/3957/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:7:p:3957-:d:780268

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().